Page last updated: 2024-09-05
sb 216763 and leptin
sb 216763 has been researched along with leptin in 1 studies
Compound Research Comparison
Studies (sb 216763) | Trials (sb 216763) | Recent Studies (post-2010) (sb 216763) | Studies (leptin) | Trials (leptin) | Recent Studies (post-2010) (leptin) |
---|---|---|---|---|---|
342 | 0 | 225 | 25,940 | 1,628 | 11,468 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, J; Hu, W; Hu, X; Huang, J; Jiang, Z; Liu, X; Nan, J; Ni, C; Su, S; Wang, C; Wang, J; Wang, Y; Wu, R; Yang, F; Yu, H; Zeng, Z; Zhang, N; Zhao, J; Zhu, K; Zhu, W | 1 |
Other Studies
1 other study(ies) available for sb 216763 and leptin
Article | Year |
---|---|
Leptin increases mitochondrial OPA1 via GSK3-mediated OMA1 ubiquitination to enhance therapeutic effects of mesenchymal stem cell transplantation.
Topics: Animals; Glycogen Synthase Kinase 3; GTP Phosphohydrolases; Humans; Indoles; Leptin; Leupeptins; Male; Maleimides; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Metalloendopeptidases; Mice; Mitochondrial Proteins; Myocardial Infarction; Proteolysis; Signal Transduction; Ubiquitination | 2018 |